Bank of New York Mellon’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $567K | Sell |
38,773
-994
| -2% | -$14.7K | ﹤0.01% | 3683 |
|
|
2026
Q1 | $577K | Sell |
39,767
-738
| -2% | -$8.57K | ﹤0.01% | 3532 |
|
|
2025
Q4 | $389K | Sell |
40,505
-9,585
| -19% | -$91.8K | ﹤0.01% | 3733 |
|
|
2025
Q3 | $471K | Buy |
50,090
+3,059
| +7% | +$29.2K | ﹤0.01% | 3633 |
|
|
2025
Q2 | $498K | Sell |
47,031
-1,323
| -3% | -$16.7K | ﹤0.01% | 3512 |
|
|
2025
Q1 | $727K | Sell |
48,354
-2,175
| -4% | -$36.2K | ﹤0.01% | 3245 |
|
|
2024
Q4 | $832K | Buy |
50,529
+8,711
| +21% | +$172K | ﹤0.01% | 3265 |
|
|
2024
Q3 | $1.03M | Sell |
41,818
-19,662
| -32% | -$510K | ﹤0.01% | 3127 |
|
|
2024
Q2 | $1.56M | Buy |
61,480
+10,439
| +20% | +$271K | ﹤0.01% | 2943 |
|
|
2024
Q1 | $1.3M | Sell |
51,041
-4,438
| -8% | -$107K | ﹤0.01% | 3009 |
|
|
2023
Q4 | $1.26M | Sell |
55,479
-5,619
| -9% | -$116K | ﹤0.01% | 3073 |
|
|
2023
Q3 | $1.14M | Sell |
61,098
-77,984
| -56% | -$1.62M | ﹤0.01% | 3078 |
|
|
2023
Q2 | $3.61M | Sell |
139,082
-5,738
| -4% | -$154K | ﹤0.01% | 2494 |
|
|
2023
Q1 | $4.16M | Sell |
144,820
-2,001
| -1% | -$59.6K | ﹤0.01% | 2397 |
|
|
2022
Q4 | $4.35M | Sell |
146,821
-3,660
| -2% | -$104K | ﹤0.01% | 2418 |
|
|
2022
Q3 | $3.58M | Buy |
150,481
+12,531
| +9% | +$288K | ﹤0.01% | 2490 |
|
|
2022
Q2 | $3.08M | Buy |
137,950
+4,847
| +4% | +$108K | ﹤0.01% | 2591 |
|
|
2022
Q1 | $3.34M | Buy |
133,103
+844
| +0.6% | +$25.7K | ﹤0.01% | 2645 |
|
|
2021
Q4 | $4.74M | Sell |
132,259
-7,127
| -5% | -$285K | ﹤0.01% | 2491 |
|
|
2021
Q3 | $5.93M | Sell |
139,386
-3,366
| -2% | -$139K | ﹤0.01% | 2400 |
|
|
2021
Q2 | $6.18M | Sell |
142,752
-15,057
| -10% | -$641K | ﹤0.01% | 2390 |
|
|
2021
Q1 | $6.44M | Sell |
157,809
-1,388
| -0.9% | -$52.6K | ﹤0.01% | 2328 |
|
|
2020
Q4 | $7.21M | Sell |
159,197
-6,403
| -4% | -$243K | ﹤0.01% | 2175 |
|
|
2020
Q3 | $5.86M | Sell |
165,600
-38,902
| -19% | -$1.41M | ﹤0.01% | 2134 |
|
|
2020
Q2 | $7.72M | Sell |
204,502
-4,627
| -2% | -$152K | ﹤0.01% | 1979 |
|
|
2020
Q1 | $6.05M | Sell |
209,129
-14,802
| -7% | -$599K | ﹤0.01% | 1981 |
|
|
2019
Q4 | $11.6M | Sell |
223,931
-11,095
| -5% | -$644K | ﹤0.01% | 1884 |
|
|
2019
Q3 | $12.9M | Sell |
235,026
-20,476
| -8% | -$1.05M | ﹤0.01% | 1792 |
|
|
2019
Q2 | $10.4M | Sell |
255,502
-3,236
| -1% | -$118K | ﹤0.01% | 1943 |
|
|
2019
Q1 | $7.82M | Buy |
258,738
+244
| +0.1% | +$8.36K | ﹤0.01% | 2098 |
|
|
2018
Q4 | $8.69M | Sell |
258,494
-26,271
| -9% | -$948K | ﹤0.01% | 1989 |
|
|
2018
Q3 | $12M | Sell |
284,765
-217,938
| -43% | -$8.61M | ﹤0.01% | 1918 |
|
|
2018
Q2 | $16.1M | Sell |
502,703
-23,666
| -4% | -$975K | ﹤0.01% | 1733 |
|
|
2018
Q1 | $26.2M | Sell |
526,369
-1,017
| -0.2% | -$57.5K | 0.01% | 1400 |
|
|
2017
Q4 | $28.4M | Sell |
527,386
-13,996
| -3% | -$775K | 0.01% | 1371 |
|
|
2017
Q3 | $31.4M | Buy |
541,382
+50,949
| +10% | +$2.66M | 0.01% | 1284 |
|
|
2017
Q2 | $24.2M | Buy |
490,433
+213,055
| +77% | +$9.81M | 0.01% | 1427 |
|
|
2017
Q1 | $12M | Buy |
277,378
+19,457
| +8% | +$929K | ﹤0.01% | 1859 |
|
|
2016
Q4 | $12.6M | Buy |
257,921
+53,922
| +26% | +$2.49M | ﹤0.01% | 1833 |
|
|
2016
Q3 | $9.76M | Sell |
203,999
-1,097
| -0.5% | -$54.2K | ﹤0.01% | 1894 |
|
|
2016
Q2 | $11M | Sell |
205,096
-29,988
| -13% | -$1.41M | ﹤0.01% | 1798 |
|
|
2016
Q1 | $10.5M | Sell |
235,084
-7,962
| -3% | -$323K | ﹤0.01% | 1811 |
|
|
2015
Q4 | $9.28M | Sell |
243,046
-40,211
| -14% | -$1.54M | ﹤0.01% | 1880 |
|
|
2015
Q3 | $9.02M | Buy |
283,257
+7,332
| +3% | +$256K | ﹤0.01% | 1920 |
|
|
2015
Q2 | $9.11M | Buy |
275,925
+8,829
| +3% | +$315K | ﹤0.01% | 2012 |
|
|
2015
Q1 | $11M | Buy |
267,096
+22,429
| +9% | +$907K | ﹤0.01% | 1896 |
|
|
2014
Q4 | $9.97M | Buy |
244,667
+8,809
| +4% | +$344K | ﹤0.01% | 1916 |
|
|
2014
Q3 | $8.65M | Buy |
235,858
+29,492
| +14% | +$1.27M | ﹤0.01% | 1990 |
|
|
2014
Q2 | $9.56M | Buy |
206,366
+28,163
| +16% | +$1.25M | ﹤0.01% | 1951 |
|
|
2014
Q1 | $7.33M | Buy |
178,203
+39,024
| +28% | +$1.45M | ﹤0.01% | 2096 |
|
|
2013
Q4 | $5.31M | Buy |
139,179
+52,199
| +60% | +$1.61M | ﹤0.01% | 2262 |
|
|
2013
Q3 | $2.08M | Buy |
86,980
+274
| +0.3% | +$6.15K | ﹤0.01% | 2833 |
|
|
2013
Q2 | $1.47M | Buy |
+86,706
| New | +$1.25M | ﹤0.01% | 2956 |
|
Other funds holding ANIK
CM
N
HIM
Bank of New York Mellon's ANIK Position: Q2 2026 in Review
Bank of New York Mellon reduced its Anika Therapeutics (ANIK) stake by 2.5% in Q2 2026, selling an estimated $14.7K and leaving 38,773 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.
Bank of New York Mellon first reported a position in ANIK in Q2 2013 and has held it in 53 quarters since. The position peaked at $31.4M in Q3 2017. 68 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.
- Bank of New York Mellon held 38,773 shares of Anika Therapeutics worth $567K as of Q2 2026.
- Bank of New York Mellon sold 994 Anika Therapeutics shares in Q2 2026, an estimated $14.7K.
- Anika Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3683 holding.
- Bank of New York Mellon first reported a position in Anika Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Anika Therapeutics position peaked at $31.4M in Q3 2017.
- 68 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.